Finvector Oy

Where the EU money came from

Funding by EU programme. Amounts are Finvector Oy's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• CardioReGenixPartner

  CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  €240ktheir share
• ReGenHeartPartner

  Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €617ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Pohjois-Savon Sairaanhoitopiirin KuntayhtymaFinland · 2 shared projects
• A2f Associates LimitedUnited Kingdom · 2 shared projects
• University College LondonUnited Kingdom · 1 shared project
• The University of EdinburghUnited Kingdom · 1 shared project
• King'S College LondonUnited Kingdom · 1 shared project
• Vrije Universiteit BrusselBelgium · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• Medizinische Universitaet WienAustria · 1 shared project
• Queen Mary University of LondonUnited Kingdom · 1 shared project
• Ita-Suomen YliopistoFinland · 1 shared project
• Region HovedstadenDenmark · 1 shared project
• Christian-Albrechts-Universitaet zu KielGermany · 1 shared project
• Servicio Madrileno de SaludSpain · 1 shared project
• Medizinische Hochschule HannoverGermany · 1 shared project
• Asphalion SLSpain · 1 shared project
• Slaski Uniwersytet Medyczny W KatowicachPoland · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• cardiology
• gene therapy
• nuclear medicine
• pharmaceutical drugs
• stem cells
• surgery